- Home
- BW vs ABSI Comparison
BW vs ABSI Comparison
Compare BW & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BW | ABSI |
|---|---|---|
| Founded | 1867 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 997.8M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BW | ABSI |
|---|---|---|
| Price | $5.81 | $10.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $22.00 | $14.40 |
| AVG Volume (30 Days) | ★ 3.9M | 3.3M |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.46 | 10.64 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,062,388,000.00 | $4,534,000.00 |
| Revenue This Year | $78.48 | $39.03 |
| Revenue Next Year | $22.23 | $314.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.74 | $2.24 |
| 52 Week High | $22.03 | $12.06 |
Technical Indicators
Market Signals| Indicator | BW | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 32.97 | 62.14 |
| Support Level | N/A | $8.17 |
| Resistance Level | $7.82 | $11.26 |
| Average True Range (ATR) | 0.37 | 0.71 |
| MACD | -0.05 | 0.16 |
| Stochastic Oscillator | 3.72 | 87.30 |
Price Performance
Historical ComparisonAbout BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is an energy technologies provider offering energy and emissions control solutions to a broad range of industrial, electrical utility, municipal, and other customers. It offers technologies that utilize coal, natural gas, hydrogen, waste, and biomass to produce energy, environmental solutions, and carbon capture systems. The company's product portfolio comprises steam generation systems, environmental solutions, combustion and fuel systems, and related equipment and services. Additionally, it offers specialized technologies (BrightLoop) in industrial energy production, including hydrogen and syngas. Geographically, the company generates maximum revenue from the United States, and the rest from Canada, the UK, Indonesia, the Philippines, and other markets.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.